HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pedro Castanheira Selected Research

2,3,4,4- tetramethyl- 5- methylenecyclopent- 2- enone

6/2014Dose-dependent inhibition of BACE-1 by the monoterpenoid 2,3,4,4-tetramethyl-5-methylenecyclopent-2-enone in cellular and mouse models of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pedro Castanheira Research Topics

Disease

2Lafora Disease
02/2016 - 06/2010
1Breast Neoplasms (Breast Cancer)
09/2019
1Myoclonic Epilepsies (Myoclonic Encephalopathy)
02/2016
1Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy)
03/2015
1Amyloidosis
03/2015
1Cardiomyopathies (Cardiomyopathy)
03/2015
1Parkinson Disease (Parkinson's Disease)
03/2015
1Alzheimer Disease (Alzheimer's Disease)
06/2014

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
09/2019 - 06/2014
2Amyloid (Amyloid Fibrils)IBA
03/2015 - 06/2014
1IntegrinsIBA
09/2019
1ADP-Ribosylation Factors (ADP-Ribosylation Factor)IBA
09/2019
1GlycogenIBA
02/2016
1PolymersIBA
02/2016
1Prealbumin (Transthyretin)IBA
03/2015
1Monoterpenes (Monoterpenoids)IBA
06/2014
1Peptide Hydrolases (Proteases)FDA Link
06/2014
12,3,4,4- tetramethyl- 5- methylenecyclopent- 2- enoneIBA
06/2014

Therapy/Procedure

1Therapeutics
06/2010